Société Regulus Therapeutics Inc Nasdaq
Actions
US75915K1016
Recherche biotechnologique et médicale
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30/08/19 |
Chief Tech/Sci/R&D Officer | - | 29/11/22 | |
Rekha Garg
LAW | General Counsel | - | 29/11/22 |
Amin Kamel
PRN | Corporate Officer/Principal | - | 02/06/22 |
Daniel Penksa
AUD | Comptroller/Controller/Auditor | 39 | 01/06/15 |
Christopher Aker
LAW | General Counsel | 63 | 19/05/11 |
Brian K. Campion
PRN | Corporate Officer/Principal | - | 01/07/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01/06/17 |
David Baltimore
BRD | Director/Board Member | 86 | 01/01/09 |
Director/Board Member | 75 | 01/04/13 | |
Chairman | 74 | 01/01/08 | |
Jake Nunn
BRD | Director/Board Member | 54 | 11/06/19 |
Alice S. Huang
BRD | Director/Board Member | 85 | 26/01/21 |
Hugh Rosen
BRD | Director/Board Member | 64 | 02/06/16 |
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04/01/16 |
Preston Klassen
PSD | President | 55 | 22/06/23 |
Director/Board Member | 56 | 17/04/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 0 | 3 725 720 | 0 | 0 | 95,99 % |
Action B | 0 | 258 707 | 0 | 0 | |
Action C | 0 | 1 330 832 | 0 | 0 | |
Action D | 1 | 65 465 251 | 64 363 054 ( 98,32 %) | 0 | |
Action E | 0 | 256 700 | 0 | 0 |
Coordonnées société
Regulus Therapeutics, Inc.
4224 Campus Point Court Suite 210
92121, San Diego
+858 202 6300
http://www.regulusrx.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
-1,19 % | 103 Md | |
+8,85 % | 101 Md | |
+4,40 % | 23,07 Md | |
-12,15 % | 22,23 Md | |
-4,36 % | 18,05 Md | |
-39,98 % | 17,18 Md | |
-10,19 % | 16,94 Md | |
+6,72 % | 14,07 Md | |
+39,11 % | 12,35 Md |